FABP5 and neoplasm: Mechanistically, FABP5 may drive tumor progression through PPARβ/δ signaling, epithelial‐mesenchymal transition induction, angiogenesis regulation, and potential effects on fatty acid metabolism and hypoxia‐related pathways.